Daniel from Norway

Registered at the short selling broker Pepperstone, 3 minutes ago.

» Try Pepperstone you too
78.6% of retail investor accounts lose money when trading spread bets and CFDs with Pepperstone.
Don't show again

CARA Therapeutics, Inc. (CARA) shares information

Cara Therapeutics Inc


24h Change

1.08 %

CARA

Live rate: Market closed

Stock data per Friday 25 Nov, 2022

CARA
NASDAQ
11.07
10.93
11.19
0.12 (+ 1.08%)
US Market is closed

Live Stock price in graph for Cara Therapeutics Inc (CARA)

  • Latest Volume

    119,583 (-32.45 %)

  • Volume prev. day

    177,037

  • Avg. daily volume

    348,347

  • Market cap

    601,279,062

  • P/E ratio

    -6.74

  • Today high

    11.21 USD

  • Today low

    10.74 USD

  • 52 week high

    13.97 USD

  • 52 week low

    7.4 USD

  • YTD Change

    n/a

Quick links

 

Latest news about Cara Therapeutics Inc

Below you can find the most recent news posts about Cara Therapeutics Inc, primarily from US and UK based news sources.

Neutral On Cara Therapeutics Stock (NASDAQ:CARA)

Saturday, 26 November 2022, 07:32:38
I like the capital structure of Cara Therapeutics, but the company seems incapable of turning a profit. See why I”m neutral on CARA stock.
— Seeking Alpha


Cara Therapeutics Inc (CARA) Q3 2022 Earnings Call Transcript | AlphaStreet

Tuesday, 8 November 2022, 03:18:37
Cara Therapeutics Inc (NASDAQ:CARA) Q3 2022 Earnings Call dated Nov. 07, 2022.
— AlphaStreet


Cara Therapeutics, Inc. (CARA) Q3 2022 Earnings Call Transcript

Tuesday, 8 November 2022, 02:31:01
Cara Therapeutics, Inc. (NASDAQ:NASDAQ:CARA) Q3 2022 Earnings Conference Call November 07, 2022, 16:30 ET Company Participants Matthew Murphy – Manager, Investor Relations Christopher…
— Seeking Alpha


Cara Therapeutics GAAP EPS of -$0.43 beats by $0.01, revenue of $10.81M beats by $1.95M (NASDAQ:CARA)

Monday, 7 November 2022, 22:04:00
Cara Therapeutics press release (NASDAQ:CARA): Q3 GAAP EPS of -$0.43 beats by $0.01.Revenue of $10.81M (-46.7% Y/Y) beats by $1.95M.
— Seeking Alpha


Cara Therapeutics Reports Third Quarter 2022 Financial Results

Monday, 7 November 2022, 22:01:00
– Net revenue was $16.2M for 3Q22 including profit-sharing revenue of $7.4M from KORSUVA ® (difelikefalin) injection –
— GlobeNewswire


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have CARA available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.